Active Ingredient History
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Adenocarcinoma (Phase 1/Phase 2)
Biliary Tract Neoplasms (Phase 1)
Carcinoma, Non-Small-Cell Lung (Phase 1)
Colonic Neoplasms (Phase 1/Phase 2)
Colorectal Neoplasms (Phase 1/Phase 2)
Endometrial Neoplasms (Phase 1)
Glioblastoma (Early Phase 1)
Glioma (Early Phase 1)
Healthy Volunteers (Phase 1)
Leukemia, Lymphocytic, Chronic, B-Cell (Phase 1)
Leukemia, Myeloid, Acute (Phase 1)
Lymphoma, B-Cell, Marginal Zone (Phase 1)
Lymphoma, Mantle-Cell (Phase 1)
Melanoma (Phase 1)
Mutation (Phase 2)
Neoplasm Metastasis (Phase 2)
Neoplasms (Phase 2)
Ovarian Neoplasms (Phase 1)
Pancreatic Neoplasms (Phase 2)
Proto-Oncogene Proteins B-raf (Phase 2)
Waldenstrom Macroglobulinemia (Phase 1)
Trial | Phase | Start Date | Organizations | Indications |
---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue